Back to Search Start Over

Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCANĀ® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer.

Authors :
Tippey, Kathryn G.
Yovanoff, Mary
McGrath, Larry S.
Sneeringer, Peter
Source :
Pain & Therapy. Jun2019, Vol. 8 Issue 1, p89-98. 10p.
Publication Year :
2019

Abstract

Introduction: Opioid overdose rescue situations are time-critical, high-stress scenarios that frequently require nonmedical first responders or bystanders to intervene and administer naloxone to avoid opioid-induced fatalities. Training nonmedical personnel to respond during such mentally constraining situations presents the human factors challenge of how best to design a safe and effective lay delivery system. This paper comparatively evaluates the ease of use of two nasal naloxone administration products: NARCAN® Nasal Spray and a naloxone prefilled syringe with nasal atomizer (PFS-NA). Methods: We evaluated the use requirements and usability of NARCAN® Nasal Spray versus a naloxone PFS-NA using a systems-oriented method. First, we determined the use requirements of different user groups. Next, we focused on constructing a human factors task analysis of both products. Finally, we conducted a comparative risk assessment of the tasks that were different between the two products. Results: Inexperienced users, such as nonmedical first responders and bystanders, are at the highest risk of incorrectly administering naloxone, particularly in high-stress emergency opioid overdose situations. The device Preparation and Medication Delivery tasks most differentiate the use of NARCAN® Nasal Spray and a PFS-NA. The level of task complexity and number of steps within those tasks is substantially greater for a PFS-NA than for the NARCAN® Nasal Spray. Conclusions: NARCAN® Nasal Spray requires fewer steps and is easier to administer than a naloxone PFS-NA. Thus, using NARCAN® Nasal Spray should increase the likelihood that nonmedical personnel correctly deliver naloxone in time-critical, high-stress opioid overdose rescue situations. Funding: ADAPT Pharma, Inc. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
21938237
Volume :
8
Issue :
1
Database :
Academic Search Index
Journal :
Pain & Therapy
Publication Type :
Academic Journal
Accession number :
136417120
Full Text :
https://doi.org/10.1007/s40122-019-0118-0